FDA OKs Blueprint/Roche's Gavreto As Rival To Lilly's Retevmo

US Launch For RET Drug Within A Week

 
• By Kevin Grogan
Cheetahs
Roche and Blueprint Pursuing Lilly • Source: Shutterstock

More from New Products

More from Scrip